Skip to main content
. 2016 Jan 18;8(2):92–106. doi: 10.4254/wjh.v8.i2.92

Table 1.

Classification of new antiviral drugs

NS3/4A PIs First-generation protease inhibitors
Telaprevir
Boceprevir
Second-generation protease inhibitors
Simeprevir
Faldaprevir
Paritaprevir
Ritonavir
NS5B NPIs Sofosbuvir
NS5B NNPIs Dasabuvir
NS5A inhibitors Daclatasvir
Ledipasvir
Ombitasvir

PIS: Protease inhibitors; NPIs: Nucleoside polymerase inhibitors; NNPIs: Non-nucleoside polymerase inhibitors.